Diamedica Therapeuti Revenue and Competitors
Estimated Revenue & Valuation
- Diamedica Therapeuti's estimated annual revenue is currently $6.2M per year.
- Diamedica Therapeuti's estimated revenue per employee is $155,000
Employee Data
- Diamedica Therapeuti has 40 Employees.
- Diamedica Therapeuti grew their employee count by 5% last year.
Diamedica Therapeuti's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP, Clinical Development Operations | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Senior Director Manufacturing | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | Chief Business Officer | Reveal Email/Phone |
6 | Sr. Director Quality Assurance | Reveal Email/Phone |
7 | Director Clinical Operation | Reveal Email/Phone |
8 | Chief Commercial Officer | Reveal Email/Phone |
9 | Associate Director, Pharmacovigilance | Reveal Email/Phone |
10 | Chief Medical Officer | Reveal Email/Phone |
Diamedica Therapeuti Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.8M | 50 | 9% | N/A | N/A |
#2 | $7.4M | 48 | -35% | N/A | N/A |
#3 | $0.9M | 6 | 20% | N/A | N/A |
#4 | $0.3M | 2 | -91% | N/A | N/A |
#5 | $3.6M | 23 | 5% | N/A | N/A |
#6 | $0.9M | 6 | -33% | N/A | N/A |
#7 | $5M | 32 | 3% | N/A | N/A |
#8 | $14.7M | 95 | 9% | N/A | N/A |
#9 | $14.7M | 95 | 0% | $20.5M | N/A |
#10 | $27.9M | 144 | 13% | $39.1M | N/A |
What Is Diamedica Therapeuti?
DiaMedica Therapeutics is a clinical-stage biopharmaceutical company that is developing innovative treatments where there is significant unmet clinical need or where no current therapies are available with the focus on neurological and kidney diseases. For more information please visit www.diamedica.com.
keywords:N/A
N/A
Total Funding
40
Number of Employees
$6.2M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Diamedica Therapeuti News
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for...
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing...
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for...
Other Companies in Minneapolis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.3M | 40 | 0% | $20.4M |
#2 | $3.2M | 40 | -2% | N/A |
#3 | $5.8M | 40 | 3% | N/A |
#4 | $5.6M | 40 | 8% | N/A |
#5 | $7.8M | 40 | 11% | N/A |